Christopher Hoimes, DO
Showing of 2 results
Next-Generation Immunotherapy Agents Under Study for Early-Stage Bladder Cancer
The new class of drugs known as immune checkpoint inhibitors, which target molecules that serve as checks and balances in the regulation of immune responses, are proving effective against advanced bladder cancer.
Genomics for the Next Generation
New approach at UH Seidman Cancer Center simplifies testing, integrates genomics information with other complex tests Innovations in Cancer - Winter 2016 Download PDF Joseph Willis, MD Christopher Hoimes, MD Afshin Dowlati, MD ...
Results are loading...